---
title: 'The Niche Episode 079 – Vifor + Sanifit + Inositec, Kura, Takeda, Aadi, BioCryst, USDA'
type: 'episode'
url: 'https://doc.social/episodes/the-niche-episode-079-vifor-sanifit-inositec-kura-takeda-aadi-biocryst-usda'
show: 'Life Science Today'
show_url: 'https://doc.social/podcasts/life-science-today'
published: '2021-11-30'
audio: 'unavailable — the host retired the file'
---

# The Niche Episode 079 – Vifor + Sanifit + Inositec, Kura, Takeda, Aadi, BioCryst, USDA

Double acquisitions in Switzerland, FDA holds and what that means, CMV therapy, rare + oncology continues, BioCryst draws millions, and deer. Find out more athttps://thenichepod.comStory ReferencesVifor + Sanifit + InositecKuraDifferential …

## Summary

Double acquisitions in Switzerland, FDA holds and what that means, CMV therapy, rare + oncology continues, BioCryst draws millions, and deer.

**Find out more at
**[https://thenichepod.com](https://thenichepod.com/)

**Story References
**[Vifor + Sanifit + Inositec
](https://www.biospace.com/article/vifor-pharma-doubles-down-on-kidney-disease-buys-sanifit-and-inositec/?s=79)[Kura](https://www.biospace.com/article/kura-oncology-s-early-stage-aml-asset-under-partial-hold-following-patient-death/)
[Differential Syndrome
](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248336/)[Takeda
](https://www.biospace.com/article/fda-greenlights-takeda-s-livtencity-for-post-transplant-cytomegalovirus-infection/)[Aadi
](https://www.biospace.com/article/aadi-bioscience-soars-on-approval-of-first-drug-for-ultra-rare-cancer-that-predominantly-impacts-women/?s=80)[BioCryst
](https://www.biospace.com/article/releases/biocryst-adds-350-million-in-new-financing-with-royalty-pharma-and-omers-capital-markets/?keywords=BioCryst)[USDA](https://www.biospace.com/article/sars-cov-2-prevalent-in-white-tailed-deer-but-usda-cautiously-optimistic-/)[**
**](https://formative.jmir.org/2020/7/e17293/)**
Music by Luke Goodson
**[https://www.soundcloud.com/lukegoodson](https://www.soundcloud.com/lukegoodson)

**About the Show**
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.